New research on the prevalence and risk factors for new-onset interstitial lung disease (ILD) among individuals with systemic sclerosis who previously tested negative for ILD.
The prevalence and risk factors for new-onset interstitial lung disease (ILD) among previously ILD-negative systemic sclerosis patients are reported in new research presented at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
New research on the connection between severe psoriasis and coronary microvascular dysfunction suggested that those with severe psoriasis have a higher risk of cardiovascular disease.
Researchers revealed new evidence suggesting persons with severe psoriasis are at higher cardiovascular risk in the relationship between severe psoriasis and coronary microvascular dysfunction.
A new article in Arthritis and Rheumatology suggests that extracellular vesicles, which are involved in cell-to-cell communication, may be a factor in the development of fibrosis in systemic sclerosis.